|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate显示文摘Portal vein thrombosis(PVT)represents a well-known complication during the natural course of liver cirrhosis(LC),ranging from asymptomatic cases to lifethreating conditions related to portal hypertension and hepatic decompensation.Portal flow stasis,complex acquired hypercoagulable disorders and exogenous factors leading to endothelial dysfunction have emerged as key factors for PVT development.However,PVT occurrence remains unpredictable and many issues regarding its natural history,prognostic significance and treatment are still elusive.In particular although spontaneous resolution or disease stability occur in most cases of PVT,factors predisposing to disease progression or recurrence after spontaneous recanalization are not clarified as yet.Moreover,PVT impact on LC outcome is still debated,as PVT may represent itself a consequence of liver fibrosis and hepatic dysfunction progression.Anticoagulation and transjugular intrahepatic portosystemic shunt are considered safe and effective in this setting and are recommended in selected cases,even if the safer therapeutic option and the optimal therapy duration are still unknown.Nevertheless,their impact on mortality rates should be addressed more extensively.In this review we present the most debated questions regarding PVT,whose answers should come from prospective cohort studies and large sample-size randomized trials. | Mariella Faccia Maria Elena Ainora Francesca Romana Ponziani Laura Riccardi Matteo Garcovich Antonio Gasbarrini Maurizio Pompili Maria Assunta Zocco | 2019 | World Journal of Gastroenterology2019，25，31： | 23 |
| 2 | Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2cm显示文摘AIM:To analyze the long-term prognosis in a cohort of western cirrhotic patients with single hepatocellular carcinoma treated with ethanol injection.METHODS:One-hundred forty-eight patients with solitary hepatocellular carcinoma were enrolled.The tumor diameter was lower than 2 cm in 47 patients but larger in the remaining 101 patients.The impact of some pretreatment clinical and laboratory parameters and of tumor recurrence on patients' survival was assessed.RESULTS:Among the pre-treatment parameters,only a tumor diameter of less than 2 cm was an independent prognostic factor of survival.The occurrence of new nodules in other liver segments and the neoplastic portal invasion were linked to a poorer prognosis at univariate analysis.Patients with a single hepatocellular carcinoma smaller than 2 cm showed a better 5-year cumulativesurvival(73.0% vs 47.9%)(P = 0.009),3-year local recurrence rate(29.1% vs 51.5%)(P = 0.011),and 5-year distant intrahepatic recurrence rate(52.9% vs 62.8%)(P = 0.054) compared to patients with a larger tumor.CONCLUSION:The 5-year survival rate of patients with single hepatocellular carcinoma < 2 cm undergoing ethanol injection is excellent and comparable to that achieved using radiofrequency ablation. | Maurizio Pompili Erica Nicolardi Valeria Abbate Luca Miele Laura Riccardi Marcello Covino Nicoletta De Matthaeis Antonio Grieco Raffaele Landolfi Gian Ludovico Rapaccini | 2011 | World Journal of Gastroenterology2011，17，26： | 6 |
| 3 | Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development显示文摘 | Maria Assunta Zocco Enrico Di Stasio Raimondo De Cristofaro Marialuisa Novi Maria Elena Ainora Francesca Ponziani Laura Riccardi Stefano Lancellotti Angelo Santoliquido Roberto Flore Maurizio Pompili Gian Lodovico Rapaccini Paolo Tondi Giovanni Battista G | 2009 | Journal of Hepatology2009，，4： | 5 |
| 4 | ESC/EAS Guidelines for the management of dyslipidaemias显示文摘 | Alberico L. Catapano ?eljko Reiner Guy De Backer Ian Graham Marja-Riitta Taskinen Olov Wiklund Stefan Agewall Eduardo Alegria M. John Chapman Paul Durrington Serap Erdine Julian Halcox Richard Hobbs John Kjekshus Pasquale Perrone Filardi Gabriele Riccardi | 2011 | Atherosclerosis2011，，： | 3 |
| 5 | Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment显示文摘In the last years, the development in the oncology field has been huge and rapid. In particular, the evaluation of response to anti-tumour treatments has been being object of intense research, producing significant changes. Response assessment after therapy in solid neoplasias has always used radiological imaging techniques, with tumour size reduction representing a presumed therapeutic efficacy. However, with the introduction of anti-angiogenetic drugs the evaluation of tumour size has become unsuitable because some tumours, under treatment, show only tumour perfusion changes rather than lesion shrinkage. Between different imaging techniques with contrast-enhancement, contrastenhanced ultrasound(CEUS) and, in particular, dynamic CEUS have arisen as a promising and non-invasive device for monitoring cancer treatments. Moreover, the introduction of perfusion software has even more refined the technique since it is able to provide quantitative parameters related to blood flow and blood volume that can be associated with tumour response and clinical outcome such as the progression free survival and the overall survival. Here, we give an overview of the current status of CEUS in monitoring hepatocellular carcinoma response to different kind of treatments. | Davide Roccarina Matteo Garcovich Maria Elena Ainora Laura Riccardi Maurizio Pompili Antonio Gasbarrini Maria Assunta Zocco | 2015 | World Journal of Hepatology2015，7，14： | 3 |
| 6 | NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children显示文摘 | A Chiaretti G Barone R Riccardi A Antonelli P Pezzotti O Genovese L Tortorolo G Conti | 2009 | Neurology2009，，7： | 3 |
| 7 | Diagnostic tests for hepatitis C: Recent trends in electrochemical immunosensor and genosensor analysis显示文摘Hepatitis C is a liver disease that is transmitted through contact with the blood of an infected person. An estimated 150 million individuals worldwide have been chronically infected with the hepatitis C virus(HCV). Hepatitis C shows significant genetic variation in the global population, due to the high rate of viral RNA mutation. There are six variants of the virus(HCV genotypes 1, 2, 3, 4, 5, and 6), with 15 recorded subtypes that vary in prevalence across different regions of the world. A variety of devices are used to diagnose hepatitis C, including HCV antibody test, HCV viral load test, HCV genotype test and liver biopsy. Rapid, inexpensive, sensitive, and robust analytical devices are therefore essential for effective diagnosis and monitoring of disease treatment. This review provides an overview of current electrochemical immunosensor and genosensortechnologies employed in HCV detection.There are a limited number of publications showing electrochemical biosensors being used for the detection of HCV.Due to their simplicity,specificity,and reliability,electrochemical biosensor devices have potential clinical applications in several viral infections. | Carolina V Uliana Carla S Riccardi Hideko Yamanaka | 2014 | World Journal of Gastroenterology2014，20，42： | 2 |
| 8 | Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development显示文摘 | Maria Assunta Zocco Enrico Di Stasio Raimondo De Cristofaro Marialuisa Novi Maria Elena Ainora Francesca Ponziani Laura Riccardi Stefano Lancellotti Angelo Santoliquido Roberto Flore Maurizio Pompili Gian Lodovico Rapaccini Paolo Tondi Giovanni Battista G | 2009 | Journal of Hepatology2009，，4： | 2 |
| 9 | Simulation of erosion-deposition processes at basin scale by a physically-based mathematical model显示文摘The development and application of the physically-based and spatially-distributed mathematical model CTSS8-SED is presented. The model simulates hydrologic-hydraulic processes produced by storm events and related soil erosion and sediment transport processes at basin scale in lowland areas. The model simulates (i) storm runoff,(ii) soil detachment by raindrop impact and overland flow (gross sediment yield),(iii) sediment transport by overland flow and associated erosion-deposition processes and (iv) sediment transport by stream flow and riverbed erosion-deposition processes. A quasi two-dimensional representation of water flow and sediment transport routing is made by means of interconnected cells approach. The model is applied to simulate two flooding events in the Luduea Creek basin (Santa Fe, Argentina) occurred in April 1994 and March 2007 due to extraordinary rainfalls. | Pedro A. BASILE Gerardo A. RICCARDI Erik D. ZIMMERMANN Hernán R. STENTA | 2010 | International Journal of Sediment Research2010，25，2： | 2 |
| 10 | ESC/EAS Guidelines for the management of dyslipidaemias显示文摘 | Alberico L. Catapano ?eljko Reiner Guy De Backer Ian Graham Marja-Riitta Taskinen Olov Wiklund Stefan Agewall Eduardo Alegria M. John Chapman Paul Durrington Serap Erdine Julian Halcox Richard Hobbs John Kjekshus Pasquale Perrone Filardi Gabriele Riccardi | 2011 | Atherosclerosis2011，，1： | 2 |
| 11 | Influence of Temperature on the Dielectric and Ferroelectric Properties of Bismuth Titanate Thin Films Obtained by the Polymeric Precursor Method 显示文摘 | Simoes A Z Ramireic M A Riccardi C S | 2005 | Materials Chemistry and Physics2005，92，23： | 1 |
| 12 | Numerical simulations of MCAO modal systems in open-loop and closed-loop operation显示文摘 | Femenia B Carbillet M Riccardi A | 2002 | Proceedings of SPIE2002，4494，： | 1 |
| 13 | Vinorelbine plus cisplatin versus versus cilplatia plus Nindesiue and mitomycin C in stage Ⅲ~Ⅳ non-small cell lung carcinoma:a prospective randomized study显示文摘 | Gebbia V Galetta D Riccardi F | 2002 | Lung Cancer2002，37，2： | 1 |
| 14 | Role of mycobacterial et- flux transporters in drug resistance: an unresolved question显示文摘 | De Rossi E Ainsa JA and Riccardi G | 2006 | FEMS Microbiol Rev2006，，： | 1 |
| 15 | Body weight regulation,insulin sensitivity and diabetes risk显示文摘 | RICCARDI G | 2004 | European Journal of Nutrition2004，，43： | 1 |
| 16 | Glucocorticoid-induced leucine zipper(GILZ):a new important mediator of glucocorticoid action显示文摘 | Ayroldi E Riccardi C | 2009 | FASEB J2009，23，11： | 1 |
| 17 | Dietary fiber in treatment of diabetes: myth or reaity显示文摘 | RICCARDI G | 2002 | Digestive and Liver Disease2002，34，2： | 1 |
| 18 | Protein changes in response to progressive water deficit in maize:quantitative variations and identification显示文摘 | RICCARDI F GAZEAU P DE VIENNE D | 1998 | Plant Physiology1998，117，： | 1 |
| 19 | Dietary fat, insulin sensitivity and the metabolic syndrome 显示文摘 | Riccardi G Giacco R Rivellese AA | 2004 | Clin Nutr2004，23，4： | 1 |
| 20 | Cryoenergy catheter ablation:a new technique for treatment of permanent junctional reciprocating tachycardia in children显示文摘 | Gaita F Montefusco A Riccardi R | 2004 | J Cardiovasc Electrophysiol2004，15，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员